{"id":"https://openalex.org/W3025659145","doi":null,"title":"[Inhibition of sciadopitysin against UDP-glucuronosyltransferases].","display_name":"[Inhibition of sciadopitysin against UDP-glucuronosyltransferases].","publication_year":2016,"publication_date":"2016-05-01","ids":{"openalex":"https://openalex.org/W3025659145","mag":"3025659145","pmid":"https://pubmed.ncbi.nlm.nih.gov/29874021"},"language":"zh","primary_location":{"id":"pmid:29874021","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29874021","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Yao xue xue bao = Acta pharmaceutica Sinica","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100406831","display_name":"Xinxin Wang","orcid":"https://orcid.org/0000-0002-0286-3681","observed_orcids":["https://orcid.org/0000-0002-0286-3681"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xin-xin Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101551495","display_name":"Jie Hou","orcid":"https://orcid.org/0000-0002-1711-4341","observed_orcids":["https://orcid.org/0000-0002-1711-4341","https://orcid.org/0000-0001-5182-9386"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jie Hou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101608031","display_name":"Jing Ning","orcid":"https://orcid.org/0000-0002-8035-6802","observed_orcids":["https://orcid.org/0000-0002-8035-6802"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jing Ning","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110934906","display_name":"Yongqiang Pan","orcid":"https://orcid.org/0000-0002-9073-212X","observed_orcids":["https://orcid.org/0000-0002-9073-212X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yong-qiang Pan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112517064","display_name":"Mo Hong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mo Hong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5028078249","display_name":"Bin Guo","orcid":"https://orcid.org/0000-0002-8194-9669","observed_orcids":["https://orcid.org/0000-0002-8194-9669"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bin Guo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7301,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.65399052,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"51","issue":"5","first_page":"749","last_page":"55"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.005100000184029341,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11908","display_name":"Protein Interaction Studies and Fluorescence Analysis","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sciadopitysin","display_name":"sciadopitysin","score":0.996999979019165},{"id":"https://openalex.org/keywords/udp-glucuronosyltransferase","display_name":"UDP-glucuronosyltransferase","score":0.9879999756813049},{"id":"https://openalex.org/keywords/ugt1a1","display_name":"UGT1A1","score":0.8420000076293945},{"id":"https://openalex.org/keywords/ugt1a3","display_name":"UGT1A3","score":0.8700000047683716},{"id":"https://openalex.org/keywords/ugt1a8","display_name":"UGT1A8","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ugt1a10","display_name":"UGT1A10","score":1.0},{"id":"https://openalex.org/keywords/enzyme-inhibition","display_name":"enzyme inhibition","score":0.781000018119812},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8889999985694885},{"id":"https://openalex.org/keywords/competitive-inhibition","display_name":"competitive inhibition","score":0.8240000009536743},{"id":"https://openalex.org/keywords/in-vitro-in-vivo-extrapolation","display_name":"in vitro-in vivo extrapolation","score":0.8960000276565552},{"id":"https://openalex.org/keywords/glucuronidation","display_name":"glucuronidation","score":0.8119999766349792},{"id":"https://openalex.org/keywords/4-methylumbelliferone","display_name":"4-methylumbelliferone","score":0.8529999852180481},{"id":"https://openalex.org/keywords/trifluoperazine","display_name":"trifluoperazine","score":0.7200000286102295}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7524597644805908},{"id":"https://openalex.org/C2779020807","wikidata":"https://www.wikidata.org/wiki/Q416196","display_name":"Umbelliferone","level":3,"score":0.7494985461235046},{"id":"https://openalex.org/C2775891158","wikidata":"https://www.wikidata.org/wiki/Q1752915","display_name":"Trifluoperazine","level":4,"score":0.6979755163192749},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.576680064201355},{"id":"https://openalex.org/C87644729","wikidata":"https://www.wikidata.org/wiki/Q547502","display_name":"Microsome","level":3,"score":0.5712726712226868},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5270467400550842},{"id":"https://openalex.org/C2779907587","wikidata":"https://www.wikidata.org/wiki/Q14901439","display_name":"Glucuronidation","level":4,"score":0.49554407596588135},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.48084577918052673},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.3924557566642761},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3337404727935791},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.27797937393188477},{"id":"https://openalex.org/C2781338262","wikidata":"https://www.wikidata.org/wiki/Q111812","display_name":"Coumarin","level":2,"score":0.19249308109283447},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08610895276069641},{"id":"https://openalex.org/C29688787","wikidata":"https://www.wikidata.org/wiki/Q409145","display_name":"Calmodulin","level":3,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000099148","descriptor_name":"UGT1A1 Enzyme","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014453","descriptor_name":"Glucuronosyltransferase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D020719","descriptor_name":"Glucuronides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044946","descriptor_name":"Biflavonoids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:29874021","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29874021","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Yao xue xue bao = Acta pharmaceutica Sinica","raw_type":"Journal Article"},{"id":"mag:3025659145","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29874021","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W228639597","https://openalex.org/W1892985389","https://openalex.org/W1974121584","https://openalex.org/W1979263727","https://openalex.org/W2001125416","https://openalex.org/W2012822809","https://openalex.org/W2014341998","https://openalex.org/W2022080414","https://openalex.org/W2037744796","https://openalex.org/W2038058849","https://openalex.org/W2042494227","https://openalex.org/W2046953729","https://openalex.org/W2072036446","https://openalex.org/W2110482855","https://openalex.org/W2122966188","https://openalex.org/W2124888043","https://openalex.org/W2136191240","https://openalex.org/W2142946517","https://openalex.org/W2148874251","https://openalex.org/W2150916797","https://openalex.org/W2151268696","https://openalex.org/W2170967458","https://openalex.org/W2178966769","https://openalex.org/W2410651339"],"related_works":["https://openalex.org/W4399096061","https://openalex.org/W4284965522","https://openalex.org/W4395449470","https://openalex.org/W2753780674","https://openalex.org/W4379094880","https://openalex.org/W2416569285","https://openalex.org/W2136581795","https://openalex.org/W7125494413","https://openalex.org/W2012340104","https://openalex.org/W4399790702"],"abstract_inverted_index":{"This":[0],"study":[1],"was":[2,117,161,172,221],"designed":[3],"to":[4,74,164,175,188,235,259,268],"investigate":[5],"the":[6,12,76,93,140,159,167,191,201,212,215,224,238,245,260],"inhibitory":[7,77,89,131],"effects":[8,78,132],"of":[9,15,19,26,41,79,95,112,150,181,194,203,217,230,237,240,247,264],"sciadopitysin":[10,80,128,198,231],"on":[11,81,120,133,232],"catalytic":[13],"activities":[14],"human":[16,43,47,82],"12":[17],"kinds":[18],"UDP-glucuronosyltransferases":[20],"(UGTs)":[21],"in":[22,33,84,121],"vitro.":[23,85],"The":[24,86,109,124,178,197,227],"risk":[25,111,246],"drug-drug":[27],"interactions":[28],"(DDI)":[29],"is":[30],"predicted":[31,118],"by":[32,101,115,186,205,219],"vitro-in":[34],"vivo":[35],"extrapolation":[36],"(IV-IVE).":[37],"Methods":[38],"A":[39],"panel":[40],"recombinant":[42],"UGT":[44],"isoforms":[45],"and":[46,63,92,137,157,209,243],"liver":[48],"microsome":[49],"(HLM)":[50],"as":[51,53],"well":[52],"a":[54,147],"series":[55],"substrates":[56],"including":[57],"4-methyl":[58],"umbelliferone":[59],"(4-MU),":[60],"trifluoperazine":[61],"(TFP)":[62],"N-3-carboxypropyl-4-hydroxy-1,":[64],"8-naphthalimide":[65],"(NCHN)":[66],"(UGT1A1":[67],"specific":[68],"fluorescent":[69],"probe":[70],"substrates\uff09":[71],"were":[72,99],"used":[73],"characterize":[75],"UGTs":[83],"half":[87],"maximum":[88],"concentration":[90,149],"(IC(50))":[91],"constant":[94,170],"inhibition":[96,168,216,229,263],"kinetics":[97],"(K(I))":[98],"obtained":[100],"nonlinear":[102],"regression":[103],"using":[104],"GraphPad":[105],"Prism":[106],"6.0":[107],"software.":[108],"potential":[110],"DDI":[113,261],"induced":[114],"UGT1A1":[116,182,220,233,241],"based":[119],"vitro":[122],"parameters.":[123],"results":[125],"demonstrated":[126],"that":[127],"had":[129],"strong":[130,228],"UGT1A1,":[134,154,206],"UGT1A3,":[135,155,207],"UGT1A8":[136,156],"UGT1A10,":[138,158],"with":[139,223,251],"remaining":[141],"activity":[142],"being":[143],"below":[144],"30%":[145],"at":[146,190],"final":[148],"10":[151],"\u03bcmol\u00b7L(-1).":[152,177],"For":[153],"IC(50)":[160],"0.20":[162],"\u03bcmol\u00b7L(-1)":[163,174],"1.34":[165],"\u03bcmol\u00b7L(-1),":[166],"kinetic":[169],"K(I)":[171],"0.07":[173],"2.12":[176],"AUC":[179],"ratio":[180],"can":[183],"be":[184,257],"increased":[185,244],"19%":[187],"147%":[189],"oral":[192],"dose":[193],"240":[195],"mg\u00b7d(-1).":[196],"competitively":[199],"inhibited":[200],"formation":[202],"4-MU-O-glucuronide":[204],"UGT1A8,":[208],"UGT1A10.":[210],"At":[211],"same":[213],"time,":[214],"NCHN-O-glucuronidation":[218],"consistent":[222],"competitive":[225],"inhibition.":[226],"led":[234],"reduction":[236],"metabolism":[239,266],"substrates,":[242],"DDI.":[248],"When":[249],"co-administrated":[250],"other":[252],"drugs,":[253],"special":[254],"attentions":[255],"should":[256],"given":[258],"from":[262],"drug":[265],"enzymes":[267],"prevent":[269],"serious":[270],"clinical":[271],"consequences.":[272]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2}],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2020-05-21T00:00:00"}